Skip to main content
Premium Trial:

Request an Annual Quote

US Biological, Akrivis to Co-develop Research Products

NEW YORK (GenomeWeb News) – Akrivis Technologies today said that it has inked an agreement with United States Biological to co-develop, manufacture, and sell research products based on Akrivis' Z-Tect technology.

The Z-Tect technology is a nanotechnology-based technique for detecting unusually low levels of protein and molecular targets. According to the firms, the technology has "ultra-low limits of detection several thousand fold lower than currently achievable," and will make it possible to "vastly improve the early detection of cancer biomarkers in vitro."

"As we progress towards developing ultrasensitive clinical diagnostics, this agreement provides Akrivis with US Biological's extensive US and international sales and distribution channels for the broad and imminent commercialization of its Z-Tect ultrasensitive detection platform for research use," Joel Berniac, CEO of Cambridge, Mass.-based Akrivis Technologies, said in a statement. "In addition, Akrivis and US Biological will co-develop new ultrasensitive kits based on US Biological's extensive catalog of biomolecular targets, biomarkers and antibodies, covering the oncology, CNS, cardiovascular, inflammation, and auto-immune therapeutic areas."

Salem, Mass.-based US Biological is a provider of antibodies, molecular biology products, and biochemicals used in research laboratories and production facilities.

Financial and further terms of the alliance were not disclosed.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.